Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from China Longevity Group Co. Ltd. ( (HK:1863) ) is now available.
China Longevity Group Company Limited reported that its production, operations and financial position remain healthy, and that it will continue to prioritise research and development of new materials and products, underscoring management’s confidence in the underlying business despite its prolonged trading halt. The company also confirmed that trading in its shares has remained suspended on the Hong Kong Stock Exchange since 14 February 2013, that the exchange has not yet moved to delist the stock, and that the Securities and Futures Commission has still not reached a decision on the firm’s long‑standing resumption application, leaving investors in a continued state of regulatory uncertainty over the stock’s eventual trading status.
More about China Longevity Group Co. Ltd.
China Longevity Group Company Limited is a Hong Kong–listed company incorporated in the Cayman Islands, engaged in production and operations that include a focus on research and development of new materials and products, indicating a manufacturing and materials-oriented business serving industrial end-markets.
For detailed information about 1863 stock, go to TipRanks’ Stock Analysis page.